Healthcare Costs of Hospitalizations Due to Aspergillosis and 25-Year Trends in Spain, 1997–2021
In the last 40 years, a significant increase in the incidence of lung infections by Aspergillus has been reported. The scarcity of studies that describe the costs of aspergillosis indicates that the economic impact of aspergillosis in the hospital environment is greater than that of other fungal inf...
Saved in:
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2024-10-01
|
| Series: | Journal of Fungi |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2309-608X/10/11/733 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1846153216697303040 |
|---|---|
| author | María Rincón Villar Montserrat Alonso-Sardón Elisa Alvarez-Artero Beatriz Rodríguez Alonso Amparo López-Bernús Ángela Romero-Alegría Javier Pardo-Lledías Moncef Belhassen-García |
| author_facet | María Rincón Villar Montserrat Alonso-Sardón Elisa Alvarez-Artero Beatriz Rodríguez Alonso Amparo López-Bernús Ángela Romero-Alegría Javier Pardo-Lledías Moncef Belhassen-García |
| author_sort | María Rincón Villar |
| collection | DOAJ |
| description | In the last 40 years, a significant increase in the incidence of lung infections by Aspergillus has been reported. The scarcity of studies that describe the costs of aspergillosis indicates that the economic impact of aspergillosis in the hospital environment is greater than that of other fungal infections. The objective of the study was to evaluate the direct healthcare costs associated with aspergillosis in the Spanish National Health System from 1997 to 2021. A retrospective nationwide longitudinal descriptive study was designed to review hospital records from the Minimum Basic Data Set of patients admitted to hospitals of the National Health System from 1997 to 2021, with a diagnosis of aspergillosis. A total of 44,586 patients were admitted for aspergillosis in the Spanish National Health System. There was a progressive increase in the average annual cost from 1997 to 2012, which reached a maximum peak, EUR 1,395,154.21 (±2,155,192.87). It decreased between 2014 and 2019, but increased again in 2020 and 2021, EUR 28,675.79 (±30,384.12). The Pearson correlation coefficient revealed a weak negative correlation between age and hospital costs and a moderate positive correlation between average length of stay and hospital costs. Our data show that the economic impact of hospitalizations for aspergillosis is significant and increasing at a rate proportionally higher than that of other prevalent diseases. Costs related to Aspergillus infection are associated mainly with respiratory diseases. The results of this economic evaluation may be useful for health authorities to develop a future economic strategy for managing this fungal infection. |
| format | Article |
| id | doaj-art-5ec5441a2fdc4bd09b114b53eb7b5ebb |
| institution | Kabale University |
| issn | 2309-608X |
| language | English |
| publishDate | 2024-10-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Journal of Fungi |
| spelling | doaj-art-5ec5441a2fdc4bd09b114b53eb7b5ebb2024-11-26T18:08:40ZengMDPI AGJournal of Fungi2309-608X2024-10-01101173310.3390/jof10110733Healthcare Costs of Hospitalizations Due to Aspergillosis and 25-Year Trends in Spain, 1997–2021María Rincón Villar0Montserrat Alonso-Sardón1Elisa Alvarez-Artero2Beatriz Rodríguez Alonso3Amparo López-Bernús4Ángela Romero-Alegría5Javier Pardo-Lledías6Moncef Belhassen-García7Servicio de Medicina Interna, Complejo Asistencial Universitario de Palencia (CAUPA), Av. Donantes de Sangre, 34005 Palencia, SpainÁrea de Medicina Preventiva y Salud Pública, Instituto de Investigación Biomédica de Salamanca (IBSAL), Centro de Investigación en Enfermedades Tropicales (CIETUS), Universidad de Salamanca, 37007 Salamanca, SpainServicio de Medicina Interna, Complejo Asistencial Universitario de Palencia (CAUPA), Av. Donantes de Sangre, 34005 Palencia, SpainServicio de Medicina Interna, Unidad de Infecciosas, Complejo Asistencial Universitario de Salamanca (CAUSA), Instituto de Investigación Biomédica de Salamanca (IBSAL), Centro de Investigación en Enfermedades Tropicales (CIETUS), Universidad de Salamanca, 37007 Salamanca, SpainServicio de Medicina Interna, Sección de Enfermedades Infecciosas, Complejo Asistencial Universitario de Salamanca (CAUSA), Instituto de Investigación Biomédica de Salamanca (IBSAL), Centro de Investigación en Enfermedades Tropicales (CIETUS), Universidad de Salamanca, Paseo San Vicente 58-182, 37007 Salamanca, SpainServicio de Medicina Interna, Unidad de Infecciosas, Complejo Asistencial Universitario de Salamanca (CAUSA), Instituto de Investigación Biomédica de Salamanca (IBSAL), Centro de Investigación en Enfermedades Tropicales (CIETUS), Universidad de Salamanca, 37007 Salamanca, SpainServicio de Medicina Interna, Hospital Marqués de Valdecilla, IDIVAL (Instituto de Investigación Valdecilla), Universidad de Cantabria, 39008 Santander, SpainServicio de Medicina Interna, Sección de Enfermedades Infecciosas, Complejo Asistencial Universitario de Salamanca (CAUSA), Instituto de Investigación Biomédica de Salamanca (IBSAL), Centro de Investigación en Enfermedades Tropicales (CIETUS), Universidad de Salamanca, Paseo San Vicente 58-182, 37007 Salamanca, SpainIn the last 40 years, a significant increase in the incidence of lung infections by Aspergillus has been reported. The scarcity of studies that describe the costs of aspergillosis indicates that the economic impact of aspergillosis in the hospital environment is greater than that of other fungal infections. The objective of the study was to evaluate the direct healthcare costs associated with aspergillosis in the Spanish National Health System from 1997 to 2021. A retrospective nationwide longitudinal descriptive study was designed to review hospital records from the Minimum Basic Data Set of patients admitted to hospitals of the National Health System from 1997 to 2021, with a diagnosis of aspergillosis. A total of 44,586 patients were admitted for aspergillosis in the Spanish National Health System. There was a progressive increase in the average annual cost from 1997 to 2012, which reached a maximum peak, EUR 1,395,154.21 (±2,155,192.87). It decreased between 2014 and 2019, but increased again in 2020 and 2021, EUR 28,675.79 (±30,384.12). The Pearson correlation coefficient revealed a weak negative correlation between age and hospital costs and a moderate positive correlation between average length of stay and hospital costs. Our data show that the economic impact of hospitalizations for aspergillosis is significant and increasing at a rate proportionally higher than that of other prevalent diseases. Costs related to Aspergillus infection are associated mainly with respiratory diseases. The results of this economic evaluation may be useful for health authorities to develop a future economic strategy for managing this fungal infection.https://www.mdpi.com/2309-608X/10/11/733aspergillosishuman aspergillosisinvasive fungal diseaseseconomichealthcare costsSpain |
| spellingShingle | María Rincón Villar Montserrat Alonso-Sardón Elisa Alvarez-Artero Beatriz Rodríguez Alonso Amparo López-Bernús Ángela Romero-Alegría Javier Pardo-Lledías Moncef Belhassen-García Healthcare Costs of Hospitalizations Due to Aspergillosis and 25-Year Trends in Spain, 1997–2021 Journal of Fungi aspergillosis human aspergillosis invasive fungal diseases economic healthcare costs Spain |
| title | Healthcare Costs of Hospitalizations Due to Aspergillosis and 25-Year Trends in Spain, 1997–2021 |
| title_full | Healthcare Costs of Hospitalizations Due to Aspergillosis and 25-Year Trends in Spain, 1997–2021 |
| title_fullStr | Healthcare Costs of Hospitalizations Due to Aspergillosis and 25-Year Trends in Spain, 1997–2021 |
| title_full_unstemmed | Healthcare Costs of Hospitalizations Due to Aspergillosis and 25-Year Trends in Spain, 1997–2021 |
| title_short | Healthcare Costs of Hospitalizations Due to Aspergillosis and 25-Year Trends in Spain, 1997–2021 |
| title_sort | healthcare costs of hospitalizations due to aspergillosis and 25 year trends in spain 1997 2021 |
| topic | aspergillosis human aspergillosis invasive fungal diseases economic healthcare costs Spain |
| url | https://www.mdpi.com/2309-608X/10/11/733 |
| work_keys_str_mv | AT mariarinconvillar healthcarecostsofhospitalizationsduetoaspergillosisand25yeartrendsinspain19972021 AT montserratalonsosardon healthcarecostsofhospitalizationsduetoaspergillosisand25yeartrendsinspain19972021 AT elisaalvarezartero healthcarecostsofhospitalizationsduetoaspergillosisand25yeartrendsinspain19972021 AT beatrizrodriguezalonso healthcarecostsofhospitalizationsduetoaspergillosisand25yeartrendsinspain19972021 AT amparolopezbernus healthcarecostsofhospitalizationsduetoaspergillosisand25yeartrendsinspain19972021 AT angelaromeroalegria healthcarecostsofhospitalizationsduetoaspergillosisand25yeartrendsinspain19972021 AT javierpardolledias healthcarecostsofhospitalizationsduetoaspergillosisand25yeartrendsinspain19972021 AT moncefbelhassengarcia healthcarecostsofhospitalizationsduetoaspergillosisand25yeartrendsinspain19972021 |